|
Jan van Heek is Executive Vice President at Genzyme Corporation. Mr. van Heek joined Genzyme in 1991, and during his tenure at the company, has been responsible for building the worldwide therapeutics, surgical and genetic testing businesses. He established Genzyme's European offices in the early 90's and helped build Genzyme's broad portfolio of businesses and manufacturing infrastructure worldwide. In recent years, he served as Executive Vice President with overall responsibility for the therapeutic products business of Genzyme. Prior to his tenure at Genzyme, Mr. van Heek held various management positions at Baxter Healthcare Corporation in Europe and the U.S. for over a decade. He currently serves on the boards of Cardialysis CRO in Rotterdam, The Netherlands, Viacell Corporation and Zelos Therapeutics. Mr. van Heek received an MBA from St. Gallen University, Switzerland, and an executive degree from Stanford Business School, California. | 